Alice Y.Y. Cheng, MD FRCPC Peter Lin, MD CCFP

Slides:



Advertisements
Similar presentations
LMC Diabetes Advanced Diabetes Education Workshop Presented by LMC Diabetes and Endocrinology.
Advertisements

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Canadian Diabetes Association Clinical Practice Guidelines Pharmacologic Management of Type 2 Diabetes Chapter 13 William Harper, Maureen Clement, Ronald.

4-T Final Three-year Results Slides © University of Oxford Diabetes Trials Unit  4-T slides are copyright and remain the property of the University of.
Intensifying Insulin Therapy in Type 2 Diabetes: Strategies for Family Medicine Amy Aronovitz, MD Endocrinologist, Northshore University HealthSystem Chicago,
Diabetes Mellitus Cases
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Insulin initiation OPTIMISING Glycaemic control and Weight Dr C Rajeswaran Consultant Physician Diabetes & Endocrinology Mid Yorkshire NHS Trust.
Saturday May 02 PST 4 PM. Saturday May 02 PST 10:00 PM.
Clinical Protocol Using Insulin Pump Easy Guideline for Initiating Insulin Pumps on Type 2 Diabetes Patients.
Insulin therapy.
A joint investigation by Channel 4 News and the BMJ reveals the NHS spends tens of millions more than necessary on modern insulins to treat diabetes despite.
Insulin Therapy Case Studies
Case Studies on Insulin Initiation
LONG TERM BENEFITS OF ORAL AGENTS
INSULIN THERAPY IN TYPE 1 DIABETES
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Criteria for the diagnosis of DM Symptoms of diabetes plus random blood glucose concentration ≥ 200 mg/dl OR FPG ≥ 126 mg/dl OR Two –hour plasma glucose.
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
PHARMACOLOGICAL THERAPY FOR TYPE 2 DIABETES Reyhane Azizi M.D Assistant Prof. of Endocrinology and Metabolism Shahid Sadoghi University of Medical Sciences.
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.
Basal and Meal Time Insulin Case Study
Inpatient Glycemic Management
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Diabetes Update Part 2 of 3 Division of Endocrinology
Insulin Initiation and Titration for Family Physicians: Case Study #2: Andy Alice Y.Y. Cheng, MD FRCPC Peter Lin, MD CCFP.
Patient-directed titration to achieve glycaemic goals in type 2 diabetes using once-daily basal insulin: results of the TITRATE randomized controlled trial.
Clinical Practice Glycemic Management of Type 2 Diabetes Mellitus Faramarz Ismail-Beigi, M.D., Ph.D. Dr.kalantar N Engl J Med Volume 366(14):
January 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases.
Company Confidential © 2012 Eli Lilly and Company Prescribing human insulin: What do the guidelines say and what does this mean in practice? Speaker name.
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,
Insulin Elixir of life Dr. Sergio Diez Alvarez Staff Specialist Physician.
Journal Club 亀田メディカルセンター 糖尿病内分泌内科 Diabetes and Endocrine Department, Kameda Medical Center 松田 昌文 Matsuda, Masafumi 2006 年 12 月 14 日 8:20-8:50 B 棟8階 カンファレンス室.
Daily Math Review September 2-6, Monday Solve the following problems with strategies and/or algorithms 5, = 9, = 3, =
Insulin Optimisation Workshop Theingi Aung & Claire Rowell.
Special Situations In The Management Of In-Patient Hyperglycemia
Gerti Tashko, M.D. DM Journal Club 12/16/2010. The use of exenatide with insulin is not FDA approved. The study was designed to evaluate if exenatide.
INITIATION OF INSULIN THERAPY DR OKUNOWO EDM UNIT.
OCTOBER 5 TH -9 TH WARM- UPS No class Wednesday: CSI Day!
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
 Insulin Degludec  Ultra long action  Due to formation of soluble multihexamers at the injection site from which monomers gradually separate and are.
Quality of Life Matters NOT TOO HIGH… NOT TOO LOW… A PLAN FOR OPTIMIZING DIABETES MANAGEMENT IN NURSING HOMES 5. Insulin: Part 1.
Small concise points on Insulin
Insulin Initiation and Titration
Insulin Initiation and Intensification
Fig. 1. Study flow chart. Group A: intensifying oral hypoglycemic agents (OHAs; sulfonylurea+metformin dose titration or fixed-dose combination added to.
Glycemia Treatment Strategies Used In ACCORD
2012 ADA Clinical Practice Guidelines Therapies for DM- Type 2
Insulin Delivery Systems Atlanta Diabetes Associates
Copyright © 2006 American Medical Association. All rights reserved.
Insulins Roland Halil, BScPharm, ACPR, PharmD
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
Sequential insulin strategies in type 2 diabetes.
Options for Combination Therapy in Type 2 Diabetes: Comparison of the ADA/EASD Position Statement and AACE/ACE Algorithm  Timothy Bailey, MD  The American.
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Antihyperglycemic therapy in type 2 diabetes: general recommendations.
Approach to starting and adjusting insulin in type 2 diabetes.
Frequency of potential risk of hypoglycemia for each estimate method, defined as a percentage difference between the estimate and final basal rate. Frequency.
Insulin in Diabetes Management: Effective Patient Selection Is Key
Case study Your 79 y/o patient is on metformin 500 bid and last A1c was 8.1 They are 5’ 5” with bmi of 34 and can no longer walk even with a walker.
Insulin Delivery Systems Atlanta Diabetes Associates
Inpatient Insulin Management on the Wards
Insulin in Type 2 Diabetes
Glucose log of a 51-year-old patient with insulin-requiring type 2 diabetes and an A1C of 7.8% who takes 10 mg of glyburide at bedtime and 25 units of.
Presentation transcript:

Alice Y.Y. Cheng, MD FRCPC Peter Lin, MD CCFP Insulin Initiation and Titration for Family Physicians: Case Study #1: William Alice Y.Y. Cheng, MD FRCPC Peter Lin, MD CCFP

Case Study #1: William Patient history and presentation 59-year-old male stockbroker Type 2 diabetes x 8 years Weight = 90 kg A1C = 7.9% He is on metformin, an insulin secretagogue and a TZD – he is at the maximum dose of all three oral agents You have been proposing that he start insulin during the past few visits in the last year, and he is now becoming more agreeable to the idea William is a 59-year-old male stockbroker. Given his career, his lifestyle and eating patterns may be erratic. William has had type 2 diabetes for 8 years. His weight is 90 kg, and his A1C is 7.9%. He is on metformin, an insulin secretagogue and a TZD – he is at the maximum dose of all three oral agents. His physician has been proposing that he start insulin during his past few appointments over the last year, and he is now becoming more agreeable to the idea.

William’s SMBG Logbook Breakfast Lunch Dinner Before After Bedtime Sunday 9.7 9.2 7.5 Monday 9.4 10.0 6.9 Tuesday 9.0 8.6 7.8 Wednesday 9.1 8.9 Thursday 8.8 8.5 William’s SMBG logbook is  shown on this slide. According to the Canadian Diabetes Association clinical practice guidelines, his target pre-meal blood glucose should be between 4.0 and 7.0 millimoles per litre.1 However, as shown above, William’s blood glucose readings are higher than target throughout the day, and are particularly high in the morning. Reference Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201.

Case Study #1: William (cont’d) Case review William has suboptimal glycemic control, according to the guidelines He is maxed out on oral agents He continues to have high BG levels, particularly in the morning What insulin regimen would you prescribe? Clearly, William has suboptimal glycemic control, according to the guidelines. He is maxed out on oral agents, but continues to have high BG levels, particularly in the morning. What insulin regimen would be appropriate for a clinician to prescribe?

Type 2 Diabetes: Insulin Categories Basal Basal plus bolus Pre-mixed twice daily Here are the three categories of insulins.

Case Study #1: William (cont’d) The easiest insulin to start would be basal insulin at bedtime, which has the advantage of a single injection – so it is easy to remember At this point, the TZD should be discontinued (to minimize risk of edema); however, the metformin and insulin secretagogue can both be continued Since William has predominantly high fasting blood glucose levels, the easiest insulin regimen to start would be basal insulin at bedtime, which has the advantage of a single daily injection. William’s TZD medication should be discontinued to minimize the risk of edema, but the metformin and insulin secretagogue should be continued.

CHOOSE AN INSULIN CATEGORY CHOOSE A BRAND DOSING SEE REVERSE FOR TIPS Using the Ontario College of Family Physicians Insulin Prescription Tool: The first step is to choose an insulin category; we have selected basal insulin. The next step is to choose an insulin brand. Finally, complete the dosing and titration information for the basal insulin selected.

The back side of the Ontario College of Family Physicians Insulin Prescription Tool describes how to initiate and titrate basal insulin.   William will likely require 50 units of basal insulin daily, given his weight. However, per the instructions, he should be started at a low dose of 10 units, and then William will titrate accordingly.

Basal Insulin Dosing and Titration 10 1 1 4.0–7.0

Case Study #1: William Three Years Later William had achieved an A1C <7.0% over the past few years with basal insulin plus metformin and an insulin secretagogue However, in the past 6 months his A1C has started to climb; it is now 7.5% He is currently on 50 units of basal insulin daily William was achieving an A1C of less than 7.0% over the past few years with basal insulin plus metformin plus a secretagogue. However, in the past 6 months his A1C has started to climb, and is now 7.5%. He is currently on 50 units of basal insulin daily.

William’s SMBG Logbook Breakfast Lunch Dinner Before After Bedtime Sunday 6.5 12.4 10.2 11.5 8.0 Monday 5.9 13.1 7.9 6.9 Tuesday 5.7 11.2 8.1 6.7 Wednesday 5.8 12.8 Thursday 5.5 8.5 William’s SMBG logbook is  shown on this slide. According to the Canadian Diabetes Association clinical practice guidelines, his target pre-meal blood glucose should be between 4.0 and 7.0 millimoles per litre.1 However, as shown above, William’s blood glucose readings are higher than target throughout the day, and are particularly high in the morning. Reference Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201. 11

CHOOSE AN INSULIN CATEGORY DOSING SEE REVERSE FOR TIPS CHOOSE A BRAND Select a bolus insulin. Usually, when adding another insulin, the clinician should select the same brand as the insulin the patient is already taking, to maintain consistency of the device. Next, complete the dosing and titration section for the bolus insulin chosen.

To determine the dosage of bolus insulin required, one could consult the back side of Ontario College of Family Physicians Insulin Prescription Tool. This section contains suggestions regarding how to dose insulin in a basal/bolus regimen. The formal method of calculating bolus insulin is suggested in the highlighted paragraph. Alternatively, a simpler way to add bolus insulin would be to add 10% of the basal dose; because William is at 50 units of basal insulin per day, that means he would start at 5 units of bolus insulin and increase it by one unit, until he reaches the target postprandial BG level of 5 to 10 mmol/L.

Bolus Insulin Dosing and Titration 5 Although at this time William only requires 5 units of bolus insulin at breakfast, this dose will be inadequate. He will need to titrate the dose up until he has reached postprandial glycemic targets. Over time, his postprandial glycemic control will also decline at lunch and dinner. At that time, he will need to add bolus insulin at those meals.

Bolus Insulin Dosing and Titration (cont’d) 10 10 10